Collagen Solutions (COS) investor presentation 26.2.18

CEO Jamal Rushdy and new CFO Hilary Spence present a business overview and an update of the ChondroMimetic® clinical study.

http://www.piworld.co.uk/2018/03/01/collagen-solutions-cos-investor-presentation-26th-february-2018/

Jamal Rushdy CEO introduction – 00:18
Regenerative medicine overview – 01:12
What Collagen Solutions does – 2:40
Core business model – 5:53
Revenue trend – 9:39
ChondroMimetic® introduction – 10:21
Knee cartilage disease progression – 12:28
Current treatments – 14:55
ChondroMimetic® clinical study – 17:35
Study highlights – 18:31
Study data introduction – 22:16
Study results – 23:51
Market opportunities – 28:03
Key competitive differentiators – 31:55
Conclusions & next steps – 33:30
Q&A – 35:25
Other uses of ChondroMimetic®? – 35:26
US Regulation? – 37:10
How long does the treatment last? – 39:47
Other geographical markets? – 41:28
Partnerships? – 42:34
Cashflow – 44:50
End – 46:42

Finish reading with a 14 day trial

or Unlock with your email

Already have an account?
Login here